Significance of the imidazoline receptors in toxicology

  title={Significance of the imidazoline receptors in toxicology},
  author={Jennifer A. Lowry and J T Brown},
  journal={Clinical Toxicology},
  pages={454 - 469}
Abstract Introduction. The alpha-2 adrenergic (AA-2) receptor agonists and imidazolines are common exposures in the American Association of Poison Control Centers (AAPCC) National Poison Data System (NPDS). Although the interaction between the AA-2 receptor and imidazoline receptors has been extensively studied, it largely remains unknown to health-care professionals. This review describes these interactions and mechanisms by which agonists affect physiologic responses binding to these… 

Cardiovascular Effects Mediated by Imidazoline Drugs: an Update.

A brief update on the cardiovascular effects of clonidine, mox onidine, rilmenidine, and the novel imidazoline agents since representing an important therapeutic target for some cardiovascular diseases is provided.

Imidazoline receptors agonists: possible mechanisms of endothelioprotection Pharmacology and Clinical Pharmacology

Current information on the pharmacological effects of this group compounds allows us to conclude that they are a promising group for correcting endothelial dysfunction and complications associated with it.

Imidazoline receptors agonists: possible mechanisms of endothelioprotection

Current information on the pharmacological effects of this group compounds allows us to conclude that they are a promising group for correcting endothelial dysfunction and complications associated with it.

Insights into the Pharmacokinetics and In Vitro Cell-Based Studies of the Imidazoline I2 Receptor Ligand B06

B06 rescued the human dopaminergic cell line SH-SY5Y from death after treatment with 6-hydroxydopamine (6-OHDA) and showed a crucial anti-inflammatory effect in a cellular model of neuroinflammation.

Rationale for naphazoline effects in-depth study

Further studies on naphazoline content dynamics or products of its biotransformation in biological substrates and determination of half-life of the agent must be conducted to allow establishingsafe levels for different exposure pathways and harmful levels of the naphzoline with respect to its material accumulation.

Xylazine poisoning: a systematic review

Human exposure to xylazine appears to be a rising concern within the prehospital and emergency medicine setting and further research is needed to improve the care of patients exposed toxylazine.

Ligand of peripheral imidazoline receptors based on amides of heterocyclic acids C7070: effect on ishemized tissues

The C7070 showed a protective effect in ischemia-reperfusion and on the model of doxorubicin cardiomyopathy and showed a pronounced dermatoprotective activity and prevents the formation of necrosis on days 3 and 7 of the pathology.

Agmatine: multifunctional arginine metabolite and magic bullet in clinical neuroscience?

The agmatinergic system is currently one of the most promising candidates in order to pharmacologically interfere with some major diseases of the central nervous system, which are summarized in the present review.

Bicyclic -iminophosphonates as highly affinity imidazoline I2 receptor ligands for Alzheimer's Disease.

Bicycleic α-iminophosphonates are tools that may open new therapeutic avenues for I2-IR, particularly for unmet neurodegenerative conditions, and are supported by changes in molecular pathways related to cognitive decline and Alzheimer's disease.



Relevance of Imidazoline Receptors and Agmatine to Psychiatry: A Decade of Progress

The search for an endogenous ligand for imidazoline receptor(s) also has led to agmatine, a decarboxylated derivative of arginine, whose measurement in the blood and brain has opened new research opportunities.

Imidazoline receptors, novel agents and therapeutic potential.

  • G. HeadD. Mayorov
  • Biology
    Cardiovascular & hematological agents in medicinal chemistry
  • 2006
The imidazoline field has recently seen an enormous diversification with discoveries that I(1) and I(2) receptors also play a role in cell proliferation, regulation of body fat, neuroprotection, inflammation and some psychiatric disorders such as depression.

Imidazoline antihypertensive drugs: selective i(1) -imidazoline receptors activation.

There is significant interest in developing new agents with higher selectivity and affinity for I(1) -imidazoline receptors, which are also more effective in regulation of body fat, neuroprotection, inflammation, cell proliferation, epilepsy, depression, stress, cell adhesion, and pain.

beta-carboline binding to imidazoline receptors.

It is apparent from this study that many of these compounds display substantially higher affinity for the imidazoline sites, and this finding, and those showing modulation of some behavioural effects of morphine by I(2)-ligands, suggests that imidrazoline sites may be interesting new targets in drug abuse research.

Novel Targets and Techniques in Imidazoline Receptor Research a

ABSTRACT: Imidazoline binding sites are now generally accepted as being receptors. Despite this acceptance, the molecular structure and signal transduction mechanisms of these receptors are still

The I1‐imidazoline receptor: from binding site to therapeutic target in cardiovascular disease

The I1-imidazoline receptor is a specific high- affinity binding site corresponding to a functional cell-sur-face receptor mediating the antihypertensive actions of moxonidine and other second-generation centrally-acting agents, and may play a role in countering insulin resistance in an animal model of metabolic syndrome X.

Drugs Acting on Imidazoline Receptors

This review focuses on the main pharmacological and clinical properties of rilmenidine and moxonidine, paying particular attention not only to their efficacy in hypertension but also to other potential cardiovascular indications.